Product image of Imposergon (Famotidine) supplied by GNH India

Imposergon

Active Ingredient:
Famotidine
Origin:
EU

Imposergon (Famotidine)

Famotidine, the active ingredient in Imposergon, is a H2 receptor antagonist presented as an oral tablet for oral use. It reduces gastric acid production and is employed in the management of peptic ulcer disease, gastro‑oesophageal reflux disease, erosive oesophagitis, and other hypersecretory conditions. It is indicated for adult patients and is commonly prescribed in both primary and specialist care settings.

GNH India supplies Imposergon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Manufacturer / TM Owner

Rafarm Sa.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Famotidine is used to treat conditions related to excess gastric acid production.

  • Peptic ulcer disease: promotes ulcer healing by reducing acid exposure.
  • Gastro‑oesophageal reflux disease: alleviates heartburn and reflux symptoms.
  • Erosive oesophagitis: facilitates mucosal recovery by lowering gastric acidity.
  • Hypersecretory conditions (e.g., Zollinger‑Ellison syndrome): controls excessive acid output.

How It Works

  • Famotidine acts as a competitive antagonist at histamine H2 receptors located on the basolateral membrane of gastric parietal cells. By blocking histamine binding, it inhibits the cAMP‑mediated activation of the proton pump, leading to a dose‑dependent reduction in basal and stimulated gastric acid secretion. The effect persists for several hours, allowing once‑ or twice‑daily dosing, and does not interfere with the synthesis of gastric mucosa.

Side Effects

Famotidine may cause adverse reactions, most of which are mild and reversible.

Common Side Effects

  • Headache: mild to moderate intensity.
  • Dizziness: transient sensation of light‑headedness.
  • Constipation or diarrhea: changes in bowel habits.
  • Nausea: occasional upset stomach.
  • Abdominal pain: mild discomfort.
  • Rash: mild skin irritation.

Serious or Rare Side Effects

  • Anaphylaxis or angioedema: severe allergic response requiring immediate medical attention.
  • Cardiac arrhythmias: irregular heartbeats, especially in patients with pre‑existing heart disease.
  • Hepatic enzyme elevation: potential liver function abnormalities.
  • Neutropenia or thrombocytopenia: reduced white blood cells or platelets.
  • Interstitial nephritis: inflammation of kidney tissue.

Precautions & Warnings

Before initiating therapy, consider the following precautions.

  • Assess renal function: dose adjustment may be required in patients with impaired renal clearance.
  • Monitor for drug interactions: review concomitant medications that affect gastric pH or CYP metabolism.
  • Use caution in elderly: increased sensitivity to central nervous system effects.
  • Avoid abrupt discontinuation in patients with severe ulcer disease: may lead to rebound acid hypersecretion.
  • Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Famotidine can interact with several medicines; awareness helps maintain efficacy and safety.

Major Interactions (Avoid)

  • Antacids containing aluminum or magnesium: reduce famotidine absorption.
  • CYP2C19 inhibitors (e.g., fluconazole): may increase famotidine plasma levels.
  • Drugs requiring an acidic environment for absorption (e.g., ketoconazole): reduced efficacy.

Moderate Interactions (Monitor Closely)

  • Warfarin: potential increase in INR; monitor coagulation parameters.
  • Theophylline: possible elevation of plasma concentrations.
  • Antiretrovirals such as atazanavir: may affect drug levels and require dose adjustment.

Frequently Asked Questions

Imposergon contains famotidine, an H2 receptor antagonist that is prescribed to lower stomach acid. It is indicated for the treatment of peptic ulcer disease, gastro‑oesophageal reflux disease, erosive oesophagitis, and other conditions where excess gastric acid contributes to symptoms or tissue damage.

Famotidine works by competitively blocking histamine H2 receptors on gastric parietal cells. This inhibition prevents histamine‑stimulated activation of the proton pump, resulting in a reduction of both basal and stimulated gastric acid secretion, which helps heal acid‑related lesions.

The appropriate dose of Imposergon is determined by a qualified healthcare professional based on the patient’s condition, age, renal function, and response to therapy. Prescribers select the strength and dosing frequency that best matches the clinical need.

Safety data for famotidine in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss use with their physician.

To place an order, submit an enquiry on the Imposergon product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

The primary alternative to famotidine is the proton‑pump inhibitor (PPI) class, which provides a more profound and longer‑lasting acid suppression. Famotidine, as an H2 antagonist, offers a quicker onset, fewer drug‑interaction concerns, and is often chosen for mild‑to‑moderate acid‑related conditions or when PPIs are contraindicated.

Imposergon should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the tablets from moisture, excessive heat, and direct sunlight. Keep out of reach of children and do not use if the packaging is damaged.

Imposergon is taken orally with a glass of water. It can be administered with or without food, although taking it with food may reduce occasional gastrointestinal discomfort. Swallow the tablet whole; do not crush or chew unless specifically instructed by a healthcare professional.

Serious adverse events, although rare, include severe allergic reactions such as anaphylaxis or angioedema, cardiac arrhythmias, significant liver enzyme elevations, and blood‑cell abnormalities like neutropenia or thrombocytopenia. Patients should seek immediate medical attention if they experience symptoms such as difficulty breathing, swelling, irregular heartbeat, or unexplained bruising.

Imposergon should be avoided in individuals with a known hypersensitivity to famotidine or any other H2‑receptor antagonists. Patients with severe renal impairment may require dose adjustment or alternative therapy. It is also contraindicated in patients who have experienced severe allergic reactions to similar medications.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Famotidine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT